chartexchange

Kalaris Therapeutics Reports Q3 Net Loss

RTTNews | Nov 10, 2026 1:16 PM EST


(RTTNews) - Kalaris Therapeutics, Inc. (KLRS) on Tuesday, reported a lower net loss for the third quarter of 2026 compared with the same period in 2025, as operating expenses declined and other income remained positive.

Read original article